TABLE 4.
Clinical characteristics stratified by HDLC in patients with DM.
| Before propensity score matching |
After propensity score matching |
|||||
| Low HDLC group (n = 59) | Normal HDLC group (n = 41) | p-value | Low HDLC group (n = 40) | Normal HDLC group (n = 31) | p-value | |
| Sex | 0.657 | 1.000 | ||||
| Male | 41 (69.5) | 31 (75.6) | 28 (70.0) | 22 (71.0) | ||
| Female | 18 (30.5) | 10 (24.4) | 13 (30.0) | 9 (29.0) | ||
| Age, years | 0.068 | 0.600 | ||||
| ≥60 | 21 (35.6) | 23 (56.1) | 17 (42.5) | 16 (51.6) | ||
| <60 | 38 (64.4) | 18 (43.9) | 23 (57.5) | 15 (48.4) | ||
| BMI, kg/m2 | 0.043 | 0.398 | ||||
| ≥24.0 | 32 (54.2) | 13 (31.7) | 18 (45.0) | 10 (32.3) | ||
| <24.0 | 27 (45.8) | 28 (68.3) | 22 (55.0) | 21 (67.7) | ||
| Extra-hepatic disease | 1.000 | 0.991 | ||||
| Present | 19 (32.2) | 14 (34.1) | 13 (32.5) | 11 (35.5) | ||
| Absent | 40 (67.8) | 27 (65.9) | 27 (67.5) | 20 (64.5) | ||
| Hepatocellular carcinoma | 0.068 | 0.497 | ||||
| Present | 17 (28.8) | 20 (50.0) | 15 (37.5) | 15 (48.4) | ||
| Absent | 42 (71.2) | 20 (50.0) | 25 (62.5) | 16 (51.2) | ||
| Triglycerides, mmol/L | 0.466* | 1.000* | ||||
| High | 6 (10.2) | 2 (4.9) | 2 (5.0) | 1 (3.2) | ||
| Normal | 53 (89.8) | 39 (95.1) | 38 (95.0) | 30 (96.8) | ||
| ALT, IU/L | 0.055 | 0.996 | ||||
| ≥2-fold normal upper limit | 13 (22.0) | 3 (9.8) | 4 (10.00) | 3 (9.7) | ||
| 0–2-fold normal upper limit | 13 (22.0) | 6 (17.1) | 8 (20.0) | 6 (19.4) | ||
| Normal | 33 (55.9) | 32 (73.2) | 28 (7) | 22 (71.0) | ||
| AST, IU/L | 0.038 | 0.972 | ||||
| ≥2-fold normal upper limit | 16 (27.1) | 4 (9.8) | 5 (12.5) | 4 (12.9) | ||
| 0–2-fold normal upper limit | 14 (23.7) | 7 (17.1) | 10 (25.0) | 7 (22.6) | ||
| Normal | 29 (49.2) | 30 (73.2) | 25 (62.5) | 20 (64.5) | ||
| MELD score | 0.005 | 0.233 | ||||
| Median | 9.0 | 6.0 | 8.0 | 6.0 | ||
| Interquartile range | 5–14 | 4–9 | 5–12 | 4–10 | ||
| Infection | 0.002 | 0.018 | ||||
| Present | 22 (18.3) | 3 (7.3) | 13 (32.5) | 2 (6.5) | ||
| Absent | 37 (81.1) | 38 (92.7) | 27 (67.5) | 29 (93.5) | ||
Data are presented as the number with percentage or median with interquartile range. ALT, alanine transaminase; AST, aspartate aminotransferase; BMI, body mass index; DM, diabetes mellitus; HDLC, high-density lipoprotein cholesterol; MELD, model for end-stage liver disease. *Represents Fisher’s exact test.